Congressional spotlight shines on NIH researcher conflicts of interest
Disciplinary decisions and researcher misconduct at the National Institutes of Health took center stage during a congressional hearing earlier this week, The Baltimore Sun reported. One senior researcher, Thomas J. Walsh, MD, entered into dozens of unauthorized private arrangements with drug companies and failed to report an annual outside income totaling more than $100,000, The Sun reported a confidential internal NIH review as finding.
- Senators Hear How Two-Midnight Rule Harms Patients, Hospitals
- 3 Management Lessons from a Supermarket Debacle
- Medicare Advantage Carriers See 'No Choice' But to Accept Cuts
- Physicians to Appeal 'Docs v. Glocks' Ruling in FL
- IOM Identifies GME Problems, Calls for Finance Changes
- Healthcare Costs Start With What We Eat
- Revenue Cycles Get a Boost from Simple JPEG Files
- Handshaking Spreads Germs. Get Over It.
- CA Fines 8 Hospitals for Medical Errors
- Hospitals Likely to Outsource ICD-10 at Launch